July 18, 2022

Talking Medicines appoint Chief Customer Officer to drive US growth

Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of pharma-marketers, has appointed industry sales and marketing veteran Mike Strassberg as Chief Customer Officer. As the company’s first US-based appointment, Mike is set to drive the data tech’s continued growth in the US. 

Strassberg joins Talking Medicines having led sales and marketing at Eversana Intouch B2D for the last three years. With 30 years of experience in the health and life sciences industry Strassberg is ready to drive growth, build new relationships and help Talking Medicines establish its AI platform PatientMetRx®  as the premier digital source of patient voice for medical marketers and agencies.  

Based in New York, Mike will focus on new customer acquisition and will work closely with current customers to help them maximize the value of their platform subscriptions. Strassberg will draw from multiple leadership roles at top medical communication agencies management consultancies and pharma product marketing, to help Talking Medicines achieve its vision of becoming the world’s gold standard provider of patient intelligence.  

Talking Medicines opened its New Jersey office earlier this year and has already secured contracts with a number of leading US-based medical advertising agencies.  

Mike Strassberg, new Chief Customer Officer at Talking Medicines said: “For a long time patient centricity is a term which has been bandied about within the industry, without any real thought of how to make it happen in practice. Talking Medicines and the PatientMetRx®  platform give real substance to this, providing insights to marketeers and, ultimately, better outcomes for patients. It is an exciting time to join, with the innovative Patient Opinion Mapping feature showcasing just how powerful the insights from the platform can be. I am looking forward to playing my part in building Talking Medicines’ US operation.” 

Jo Halliday, Co-founder, and CEO of Talking Medicines said: “Just as Talking Medicines is the voice of patients, Mike will be the voice of our customers, providing a consistent and seamless experience, driving growth, establishing new relationships, managing current accounts, and building a global customer-centric organization. With extensive experience in the sector Mike will open doors for us and continue to expand our network. I am looking forward to collaborating closely with him as we enter an exciting phase in the growth of the business.” 

For more information on Talking Medicines visit talkingmedicines.com 

For media enquiries, please contact Frame PR:  

Harry Hussain at [email protected] | 07525 903588 

Katie Kelly at [email protected] | 07703 987 098 

THE TALKING MEDICINES BLOG

Women in data

Women in data

The pharmaceutical industry has come a long way in a short period of time. The Covid-19 pandemic has accelerated digital transformation plans and...

read more